{"gene":"TSC2","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":1995,"finding":"TSC2 protein product tuberin (180 kDa) exhibits specific GTPase-activating protein (GAP) activity towards Rap1a in vitro, stimulating its intrinsic GTPase activity; this activity resides in the C-terminal fragment of tuberin. Tuberin did not stimulate GTPase activity of Rap2, Ha-Ras, Rac, or Rho. Subcellular fractionation revealed that most tuberin resides in a membrane/particulate (100,000×g) fraction.","method":"Immunoprecipitation of native tuberin followed by GTPase activity assay; bacterially and Sf9-expressed C-terminal fragment assays; subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic assay with recombinant protein, confirmed with native immunoprecipitate, substrate specificity panel included","pmids":["7608212"],"is_preprint":false},{"year":1996,"finding":"Tuberin co-localizes with its substrate Rap1 in the Golgi apparatus of cultured cells, as demonstrated by co-localization with Golgi markers (mannosidase-II, furin) and disruption by brefeldin A treatment; tuberin shows punctate, perinuclear staining consistent with Golgi localization.","method":"Indirect immunofluorescence, double immunofluorescence with Golgi markers, brefeldin A treatment, confocal microscopy","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct subcellular localization with multiple orthogonal markers and pharmacological validation, replicated by co-localization with substrate","pmids":["8806680"],"is_preprint":false},{"year":1997,"finding":"The GAP-related domain of tuberin (encoded by exons 34–38, ~160 amino acids) is a key functional region; missense mutations within this domain (in exons 36, 37, 38) identified in TSC patients disrupt tuberin's growth-regulatory function, confirming the GAP domain's critical role.","method":"SSCP mutation analysis, direct sequencing, de novo mutation confirmation in sporadic cases","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — mutation mapping without direct biochemical reconstitution, but multiple independent patient cases converge on same domain","pmids":["9302281"],"is_preprint":false},{"year":1998,"finding":"Hamartin (TSC1 product) and tuberin (TSC2 product) physically interact in vivo, forming a complex; the interaction is mediated by predicted coiled-coil domains in each protein.","method":"Co-immunoprecipitation from cell lysates, coiled-coil domain prediction and mapping","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP demonstrated in vivo, domain mapping included, independently replicated by multiple subsequent labs","pmids":["9580671"],"is_preprint":false},{"year":2000,"finding":"Hamartin stabilizes tuberin by inhibiting its ubiquitination; tuberin is highly ubiquitinated in cells, but the fraction bound to hamartin is not ubiquitinated. Co-expression of TSC1 with TSC2 results in higher tuberin levels. The amino-terminal two-thirds of tuberin mediate its ubiquitination and hamartin stabilization.","method":"Transient transfection, co-immunoprecipitation, ubiquitination assay, domain deletion analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct ubiquitination assay, domain mapping, disease mutant comparison, multiple orthogonal methods","pmids":["11175345"],"is_preprint":false},{"year":2001,"finding":"TSC1 and TSC2 form a complex and function in a common pathway to control cellular growth; genetic analyses in Drosophila place the TSC genes in a pathway parallel to but converging downstream of Akt in insulin/PI3K signaling; TSC1 or TSC2 heterozygosity rescues lethality of loss-of-function insulin receptor mutants.","method":"Drosophila genetics, epistasis analysis, double-mutant rescue experiments","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in Drosophila with multiple allele combinations, pathway placement confirmed by suppressor analysis","pmids":["11390358"],"is_preprint":false},{"year":2001,"finding":"Tuberin is phosphorylated at serine and tyrosine residues in response to serum and other factors. Disease-related TSC2 mutations (Y1571H, P1675L) reduce tuberin phosphorylation, disrupt TSC1-TSC2 interaction, and curtail tuberin's growth inhibitory activity, demonstrating that phosphorylation regulates TSC1-TSC2 complex formation and function.","method":"Immunoprecipitation, phosphorylation assays, co-immunoprecipitation with disease mutants, overexpression growth assays in COS1 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphorylation assays with disease mutant comparison, co-IP, functional growth assay; single lab","pmids":["11290735"],"is_preprint":false},{"year":2001,"finding":"Pathological mutations in TSC1 (N198_F199delinsI; 593-595delACT) and TSC2 (G294E, I365del) that lie within the binding interface abolish or dramatically reduce hamartin-tuberin interaction. The hamartin-binding domain maps to tuberin amino acids 1–418 (requiring a coiled-coil at aa 346–371 plus N-terminal residues); non-pathogenic polymorphisms at adjacent positions do not disrupt binding.","method":"Yeast two-hybrid with deletion/point mutant constructs, co-immunoprecipitation from COS7 cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — two orthogonal systems (yeast two-hybrid + co-IP), disease vs. benign mutant discrimination, domain boundaries defined","pmids":["11741833"],"is_preprint":false},{"year":2002,"finding":"TSC2 is directly phosphorylated by Akt at multiple sites; Akt-dependent phosphorylation destabilizes TSC2 and disrupts its interaction with TSC1, thereby relieving TSC1-TSC2 inhibition of mTOR. TSC1-TSC2 inhibits S6K1 and activates 4E-BP1 through inhibition of mTOR.","method":"In vitro kinase assay (direct phosphorylation), co-immunoprecipitation, S6K and 4E-BP1 phosphorylation assays, TSC2 stability assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro kinase assay plus cellular mechanistic follow-up with multiple substrates, independently replicated","pmids":["12172553"],"is_preprint":false},{"year":2002,"finding":"Drosophila Akt/PKB directly phosphorylates Tsc2 in vitro at conserved residues Ser924 and Thr1518; mutation of these sites renders Tsc2 insensitive to Akt signaling, increases stability of the Tsc1-Tsc2 complex, and blocks all Akt-dependent growth signals in vivo.","method":"In vitro kinase assay with recombinant Akt, site-directed mutagenesis, Drosophila genetics, co-immunoprecipitation, cell size measurements","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro phosphorylation with mutagenesis confirming specific sites, in vivo genetic rescue, independently replicated","pmids":["12172554"],"is_preprint":false},{"year":2002,"finding":"PI3K/Akt pathway phosphorylates tuberin in response to insulin/IGF-1; Akt associates with hamartin-tuberin complexes and promotes tuberin phosphorylation and increased degradation of hamartin-tuberin complexes. Akt-phosphorylated tuberin loses ability to inhibit CDK2 activity via p27(kip1) degradation suppression.","method":"Co-immunoprecipitation, kinase assays with constitutively active PI3K/Akt constructs, PI3K inhibitor LY294002, p27 stability assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods, constitutively active and inhibitor approaches, confirmed in multiple labs","pmids":["12167664"],"is_preprint":false},{"year":2002,"finding":"Tuberin associates with 14-3-3 proteins in vivo; phosphorylation of Ser1210 in TSC2 is required for this interaction. 14-3-3 association inhibits TSC2 function (mTOR pathway inhibition); 14-3-3 interaction is regulated by Akt-mediated phosphorylation of tuberin.","method":"Co-immunoprecipitation, phospho-mutant analysis, S6K phosphorylation functional assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with site-specific mutant, functional assay; single lab, confirmed by parallel 14-3-3zeta study","pmids":["12364343"],"is_preprint":false},{"year":2002,"finding":"14-3-3zeta binds tuberin at multiple sites in an Akt-phosphorylation-regulated manner; 14-3-3zeta can form a ternary complex with TSC1-TSC2 without interfering with TSC1-TSC2 binding. Overexpression of 14-3-3beta antagonizes TSC1-TSC2 inhibition of S6K phosphorylation in a TSC2-interaction-dependent manner.","method":"Yeast two-hybrid screening, in vitro binding assay, co-immunoprecipitation, S6K phosphorylation assay with mutant TSC2","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus functional assay; single lab, corroborated by parallel Li et al. 2002 study","pmids":["12468542"],"is_preprint":false},{"year":2002,"finding":"Tuberin re-expression in TSC2-null LAM-derived and ELT3 cells abolishes hyperphosphorylation of ribosomal protein S6 and significantly inhibits p70S6K activity and DNA synthesis, establishing tuberin as a specific negative regulator of S6/p70S6K. Rapamycin mimics this effect, placing mTOR downstream of tuberin.","method":"Re-expression of wild-type tuberin in TSC2-null cell lines, p70S6K activity assay, S6 phosphorylation by immunoblot, DNA synthesis assay, rapamycin treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function/gain-of-function reconstitution in multiple TSC2-null cell lines, multiple orthogonal readouts","pmids":["12045200"],"is_preprint":false},{"year":2003,"finding":"TSC2 regulates HIF-1alpha levels and VEGF expression through both mTOR-dependent and mTOR-independent pathways. Loss of TSC2 results in HIF-1alpha accumulation and increased VEGF; rapamycin normalizes HIF but only partially reduces VEGF, indicating an additional mTOR-independent chromatin remodeling pathway.","method":"TSC2-null cell analysis, rapamycin treatment, HDAC inhibitor trichostatin A treatment, HIF-1alpha and VEGF reporter assays","journal":"Cancer cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection of two pathways, wild-type vs. disease-mutant TSC2 rescue; single lab","pmids":["12957289"],"is_preprint":false},{"year":2003,"finding":"Under energy starvation, AMPK directly phosphorylates TSC2 and enhances its activity. This AMPK-mediated phosphorylation of TSC2 is required for translational regulation and cell size control in response to energy deprivation, and protects cells from energy deprivation-induced apoptosis.","method":"In vitro kinase assay (AMPK phosphorylates TSC2), phospho-mutant rescue experiments, cell size measurements, apoptosis assays under energy starvation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro kinase assay, phospho-mutant loss-of-function, multiple cellular phenotype readouts, replicated by subsequent studies","pmids":["14651849"],"is_preprint":false},{"year":2004,"finding":"TSC2 has GAP activity specifically towards the small GTPase Rheb (not using the canonical arginine finger mechanism), instead employing a catalytic 'asparagine thumb'; Asn residues in TSC2 are essential for GAP activity. Rheb Arg15 (equivalent to Gly12 in Ras) is important for TSC2-stimulated hydrolysis. TSC1 is not required for TSC2 GAP activity but may serve as a regulatory component.","method":"In vitro GTPase assay with recombinant proteins, site-directed mutagenesis of TSC2 and Rheb, S6K phosphorylation functional assay, TSC1-binding defective mutant analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro GAP assay with mutagenesis defining catalytic mechanism, cellular functional validation","pmids":["15340059"],"is_preprint":false},{"year":2004,"finding":"TSC2 modulates actin dynamics and cell adhesion through its TSC1-binding domain (TSC2-HBD); expression of TSC2 or TSC2-HBD in TSC2-null cells promotes Rac1 activation, inhibition of RhoA, stress fiber disassembly, and focal adhesion remodeling. TSC1 inhibits Rac1, and TSC2 blocks this TSC1 activity.","method":"Re-expression of TSC2 and deletion constructs in TSC2-null cells, Rho/Rac pull-down activity assays, TSC1 siRNA knockdown, immunofluorescence of actin/focal adhesions","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain-specific rescue, GTPase activity assays, siRNA knockdown, multiple orthogonal readouts","pmids":["15611338"],"is_preprint":false},{"year":2004,"finding":"Tuberin (TSC2) expression increases B-Raf kinase activity and p42/44 MAPK phosphorylation via an mTOR-independent mechanism. Rheb (TSC2 GAP substrate) inhibits wild-type but not activated B-Raf, and interacts with endogenous B-Raf; B-Raf inhibition by Rheb is rapamycin-resistant, dissociable from S6K activation.","method":"TSC2 siRNA knockdown, B-Raf kinase assay, co-immunoprecipitation of Rheb and B-Raf, rapamycin treatment, farnesylation-defective Rheb mutant","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct kinase assay, co-IP, genetic dissection; single lab, mTOR-independence confirmed pharmacologically","pmids":["15150271"],"is_preprint":false},{"year":2004,"finding":"Tuberin is a component of lipid rafts and co-fractionates with caveolin-1 in low-density Triton X-100-resistant fractions; tuberin regulates caveolin-1 localization to the plasma membrane and caveolae formation. Loss of tuberin displaces caveolin-1 to a post-Golgi compartment; TSC2 re-expression reverses this. TSC2 also regulates post-Golgi vesicle transport (VSVG-GFP trafficking).","method":"Sucrose gradient fractionation, immunofluorescence, BFA-sensitive compartment analysis, Tsc2-/- cell re-expression, VSVG-GFP trafficking assay","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical fractionation plus functional rescue with wild-type vs. disease mutant, VSVG trafficking assay; single lab","pmids":["15093748"],"is_preprint":false},{"year":2005,"finding":"Erk directly phosphorylates TSC2, leading to TSC1-TSC2 complex dissociation and markedly impaired TSC2 ability to inhibit mTOR signaling, cell proliferation, and oncogenic transformation. Expression of an Erk non-phosphorylatable TSC2 mutant in TSC2+/- tumor cells blocks tumorigenicity in vivo, while wild-type TSC2 is ineffective.","method":"In vitro kinase assay (Erk phosphorylates TSC2), phospho-mutant expression, co-immunoprecipitation for complex integrity, mTOR substrate assays, in vivo tumor growth assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro kinase assay, mutagenesis, in vivo tumor suppression validation with phospho-null mutant","pmids":["15851026"],"is_preprint":false},{"year":2005,"finding":"Loss of Tsc1 or Tsc2 in hippocampal neurons triggers enlargement of somas and dendritic spines and alters glutamatergic synapse properties. Morphological changes require regulation of cofilin via LIM-kinase phosphorylation, which is increased by loss of Tsc2, placing TSC2 upstream of the LIM-kinase/cofilin actin regulatory pathway in neurons.","method":"Conditional knockout mouse neurons (CA1 pyramidal cells), spine size imaging, electrophysiology, LIM-kinase phospho-cofilin western blotting, rescue experiments","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function in neurons with defined phenotype (morphology + electrophysiology), pathway mechanism identified (cofilin phosphorylation)","pmids":["16286931"],"is_preprint":false},{"year":2005,"finding":"TSC2 is a cyclin D binding protein; coexpression of cyclin D1-CDK4/6 leads to increased TSC2 phosphorylation and decreased levels of both TSC2 and TSC1 proteins, promoting mTOR substrate phosphorylation (4E-BP1, S6K1). Cyclin D1 can regulate TSC1-TSC2 independently of CDK4/6 catalytic activity.","method":"Co-immunoprecipitation, phosphorylation assays, TSC protein level measurements, CDK inhibitor and kinase-dead CDK6, mTOR substrate phosphorylation, cell size assay","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, biochemical and functional assays, CDK-independent mechanism demonstrated; single lab","pmids":["16357142"],"is_preprint":false},{"year":2006,"finding":"TSC1 stabilizes TSC2 by excluding the HERC1 ubiquitin ligase (a 532-kDa HECT-domain E3) from the TSC2 complex; disease mutations in TSC2 that result in protein destabilization allow HERC1 binding even in the presence of TSC1, revealing a mechanism by which TSC1 protects TSC2 from ubiquitin-mediated degradation.","method":"Co-immunoprecipitation identifying HERC1 as TSC2-interacting protein, competitive binding assay with TSC1, disease mutant analysis, TSC2 stability measurements","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP of endogenous proteins, competitive binding, disease mutant mechanistic insight; single lab","pmids":["16464865"],"is_preprint":false},{"year":2006,"finding":"TSC1/TSC2 complex has negative and positive effects on TORC1 and TORC2 respectively. In Drosophila S2 cells, Rheb (TSC2's GAP substrate) inhibits dTORC2 activity via a dTORC1/dS6K feedback mechanism. In human cells, TSC1/2 positively affects TORC2 activity (measured by Akt-Ser473 phosphorylation).","method":"S6K and Akt phosphorylation assays as functional readouts for TORC1/2 in Drosophila S2 cells and HEK293 cells, siRNA knockdown","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays in two cell systems, mechanistic feedback identified; single lab","pmids":["16627617"],"is_preprint":false},{"year":2006,"finding":"Akt phosphorylation of tuberin triggers cytoplasmic retention of tuberin (downregulation of nuclear tuberin). In arrested G0 cells with low Akt activity, significant tuberin fraction localizes to the nucleus. Tuberin retains ability to regulate p70S6K in both cytoplasm and nucleus independently of mTOR/p70S6K regulation of p27.","method":"Nuclear/cytoplasmic fractionation, immunofluorescence, Akt inhibition and activation, cell cycle synchronization (G0 arrest)","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — fractionation plus immunofluorescence, Akt activity correlation; single lab, functional link to p70S6K demonstrated","pmids":["16862180"],"is_preprint":false},{"year":2006,"finding":"Tuberin triggers apoptosis via a pathway involving downregulation of p70S6K, reduction of BAD Ser136 phosphorylation, and upregulation of BAD/BCL-2 and BAD/BCL-XL interactions. BAD-knockout cells establish BAD as a required mediator of tuberin's pro-apoptotic effects. AKT phosphorylation negatively regulates tuberin's ability to trigger apoptosis.","method":"Tuberin overexpression, BAD-/- MEFs, co-immunoprecipitation of BAD/BCL-2/BCL-XL, p70S6K and BAD phosphorylation assays, apoptosis measurements","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (BAD-KO cells) plus biochemical pathway dissection; single lab","pmids":["16702951"],"is_preprint":false},{"year":2008,"finding":"FBW5, a DDB1-binding WD40 protein, recruits TSC2 to the DDB1-CUL4-ROC1 E3 ubiquitin ligase complex to promote TSC2 ubiquitination and degradation. Overexpression of FBW5 or CUL4A promotes TSC2 degradation, which is abrogated by TSC1 co-expression. Depletion of FBW5, DDB1, or CUL4A/B stabilizes TSC2. Drosophila Ddb1/Cul4 mutations cause Gigas/TSC2 accumulation.","method":"Co-immunoprecipitation (FBW5-TSC2-DDB1-CUL4-ROC1), siRNA knockdown, TSC2 stability assays, Drosophila genetic analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — biochemical complex reconstitution, siRNA depletion, overexpression, and in vivo Drosophila genetic validation; multiple orthogonal approaches","pmids":["18381890"],"is_preprint":false},{"year":2002,"finding":"Hamartin and tuberin are multicompartmental proteins found in cytosolic, microsomal, and cytoskeletal fractions where they form a stable complex. Within the microsomal fraction they behave as peripheral membrane proteins. Immunoisolation of tuberin-bound vesicles shows enrichment of Rap1, Rab5, and caveolin-1.","method":"Cell fractionation, co-immunoprecipitation in each fraction, immunoisolation with magnetic beads, colocalization immunofluorescence","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical fractionation with co-IP in each compartment, immunoisolation; single lab","pmids":["12147258"],"is_preprint":false},{"year":2005,"finding":"Cell migration and invasiveness of LAM cells is increased and is abolished by TSC2 re-expression. TSC2 inhibits cell migration through its N-terminus (independent of GAP activity) by associating with TSC1 and regulating RhoA activity; RhoA is activated in LAM cells and its pharmacological inhibition abolishes LAM cell migration.","method":"Migration and invasion assays, TSC2 re-expression, N-terminal domain constructs, TSC1 siRNA knockdown, RhoA pull-down activity assay, Rho inhibitor pharmacology","journal":"American journal of respiratory cell and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-specific reconstitution, RhoA activity assay, siRNA, pharmacological inhibition; single lab","pmids":["16388022"],"is_preprint":false},{"year":2007,"finding":"Tuberin regulates expression of the DNA repair enzyme OGG1 via the transcription factor NF-YA; TSC2-null cells have markedly decreased OGG1 mRNA, protein and activity, accumulate 8-oxodG, and show reduced NF-YA binding to the OGG1 promoter. Re-introduction of TSC2 cDNA into tuberin-deficient cells restores NF-YA and OGG1 expression.","method":"siRNA knockdown of TSC2, TSC2-null MEFs (TSC2-/- and +/-), ChIP, EMSA (gel shift), OGG1 promoter reporter assay, TSC2 cDNA rescue","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple TSC2 loss models, ChIP, promoter reporter, and rescue; single lab","pmids":["17989114"],"is_preprint":false},{"year":2009,"finding":"Tsc2-null cells lacking TSC2 have attenuated mTORC2 activity. mTORC2 (via rictor) modulates TSC2-null cell proliferation and survival through RhoA GTPase and Bcl2 proteins. Constitutively active V14RhoA reverses growth inhibition induced by rictor siRNA or TSC2 re-expression, placing RhoA downstream of mTORC2 in TSC2-null cells.","method":"siRNA knockdown of mTOR pathway components (raptor, rictor, Rheb), constitutively active RhoA rescue, apoptosis assays, RhoA pull-down, in vivo tumor growth","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic pathway dissection via siRNA, constitutively active rescue, in vivo validation; single lab","pmids":["21482669"],"is_preprint":false},{"year":2010,"finding":"Tsc2 haploinsufficiency in mice causes aberrant retinogeniculate projections (EphA-dependent axon guidance defects). EphA receptor activation by ephrin-A ligands inhibits ERK1/2 and decreases ERK1/2-mediated inhibition of Tsc2, thereby inactivating the mTOR pathway. Tsc2 deficiency and hyperactive Rheb constitutively activate mTOR and inhibit ephrin-induced growth cone collapse.","method":"Tsc2+/- mouse retinogeniculate projection analysis, ephrin-A stimulation, ERK1/2 and Tsc2 phosphorylation assays, growth cone collapse assay, constitutively active Rheb expression","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo mouse model plus cellular mechanistic dissection, kinase pathway hierarchy defined, multiple orthogonal assays","pmids":["20062052"],"is_preprint":false},{"year":2010,"finding":"Tuberin regulates E-cadherin localization to the plasma membrane via an Akt/mTORC1/CLIP170-dependent, rapamycin-sensitive pathway; Tsc2-null cells display loss of plasma membrane E-cadherin leading to reduced cell-cell adhesion, EMT markers (loss of E-cadherin/occludin, gain of Snail/SMA), and anchorage-independent growth.","method":"Tsc2-/- cell analysis, rapamycin treatment, CLIP170 knockdown, E-cadherin localization by immunofluorescence, EMT marker western blots, anoikis assay","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway (Akt/mTORC1/CLIP170) dissected pharmacologically, multiple cellular phenotypes; single lab","pmids":["20813961"],"is_preprint":false},{"year":2010,"finding":"TACC3 physically interacts with TSC2; they co-localize and co-purify with nuclear envelope components. TACC3 is required for proper localization of phospho-Ser939 TSC2 at spindle poles and cytokinetic bridges. Tsc2-deficient cells show abscission defects and increased binucleated cells; TSC2 acts epistatically to TACC3 in regulating cell division.","method":"TACC3 interactome mapping (co-IP/MS), co-localization microscopy, Tsc2/Tacc3 siRNA knockdown, cell division phenotype analysis, epistasis analysis","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP/MS plus functional localization and epistasis; single lab","pmids":["20237422"],"is_preprint":false},{"year":2010,"finding":"Loss of tuberin in TSC2-null cells promotes invasion through a β-catenin-dependent mechanism; tuberin-null cells express cleaved forms of β-catenin that are transcriptionally active and drive MMP7 expression, which mediates invasion.","method":"β-catenin reporter assay, MMP7 expression analysis, invasion assays, TSC2-null cell analysis, LAM tissue immunostaining","journal":"American journal of respiratory cell and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay, expression analysis, and functional invasion assay; single lab with tissue validation","pmids":["20042714"],"is_preprint":false},{"year":2019,"finding":"PKG1 (protein kinase G1, a primary effector of nitric oxide and natriuretic peptide signaling) directly phosphorylates TSC2 at S1365/S1366 (mouse; S1364/S1365 human). Phosphorylation at these sites bidirectionally controls stress-stimulated (but not basal) mTORC1 activity, suppressing hypertrophy and stimulating autophagy in cardiomyocytes. Phospho-null knockin (TSC2-S1365A) mice develop worse heart disease after pressure overload; phosphomimetic (TSC2-S1365E) mice are protected.","method":"In vitro kinase assay (PKG1 phosphorylates TSC2), phospho-null and phosphomimetic knockin mouse models, cardiac pressure overload model, cardiomyocyte hypertrophy and autophagy assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro kinase assay, bidirectional knockin mouse genetics, in vivo cardiac phenotype with mechanistic rescue","pmids":["30700906"],"is_preprint":false},{"year":2020,"finding":"Crystal structure of the TSC2 GAP domain determined; structure-based modeling of the TSC2-Rheb complex and molecular dynamics simulations identify TSC2 Asn1643 and Rheb Tyr35 as key active site residues; Rheb Arg15 and Asp65 contribute to the interface and indirectly aid catalysis rather than being catalytic residues. The GAP domain is stabilized by interactions with other TSC2 domains.","method":"X-ray crystallography, molecular dynamics simulations, TSC2-Rheb complex modeling, characterization of pathogenic TSC2 variants","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with MD simulations and mechanistic interpretation; structural validation of catalytic mechanism proposed by Li et al. 2004","pmids":["32502382"],"is_preprint":false},{"year":2021,"finding":"Lysosomal biogenesis is increased in TSC1/2-deficient cells via a TFEB-dependent mechanism that is non-canonical: in the absence of TSC1/2, TFEB is hypo-phosphorylated at mTORC1 sites because mTORC1 cannot phosphorylate TFEB without the TSC1/2 complex. Overexpression of FLCN (a RAGC GAP) or constitutively active RAGC increases TFEB phosphorylation and cytoplasmic relocalization in TSC2-deficient cells.","method":"TFEB phosphorylation assays in TSC1/2-deficient cells, FLCN overexpression, constitutively active RAGC expression, TFEB localization microscopy, TSC renal tumor/LAM tissue analysis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays in multiple TSC2-deficient models, FLCN/RAGC rescue; single lab, multiple orthogonal approaches","pmids":["34253722"],"is_preprint":false},{"year":2021,"finding":"TSC2 S1365 phosphorylation status controls myocardial substrate utilization during ischemia-reperfusion; TSC2-S1365A (phospho-null) hearts have amplified mTORC1 activation, increased glycolytic capacity, and protection against IR injury; TSC2-S1365E (phosphomimetic) hearts fail to activate mTORC1 with ischemic preconditioning and show worse IR outcomes when glucose is limiting.","method":"TSC2-S1365A and S1365E knockin mouse IR model (ex vivo and in vivo), metabolic flux measurements (OCR, EACR), lactate and acylcarnitine metabolomics, mTORC1 substrate phosphorylation","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — bidirectional knockin mouse genetics, metabolomic profiling, and defined metabolic mechanism; extends PKG1/TSC2 mechanistic work","pmids":["33401933"],"is_preprint":false},{"year":2004,"finding":"In S. pombe (fission yeast), the defect in arginine uptake in tsc2+ mutant cells (decreased expression of amino acid permeases) is rescued by dominant-negative rhb1+ (Rheb homolog) but not wild-type rhb1+, and is not rescued by a GAP-domain mutant TSC2, placing TSC2 GAP activity toward Rheb upstream of amino acid permease regulation.","method":"S. pombe tsc2+ mutant analysis, dominant-negative and wild-type rhb1+ rescue, patient-derived GAP-domain TSC2 mutant complementation, amino acid uptake assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in yeast ortholog with biochemical readout (amino acid uptake), GAP-domain mutation confirms mechanism; fission yeast ortholog","pmids":["14718525"],"is_preprint":false}],"current_model":"TSC2 (tuberin) encodes a GTPase-activating protein (GAP) that, together with TSC1 (hamartin), forms a heterodimeric complex that stimulates GTP hydrolysis by Rheb using a catalytic asparagine-thumb mechanism, thereby suppressing mTORC1-dependent translation, cell growth, and anabolic metabolism; the complex is regulated by direct phosphorylation of TSC2 by multiple kinases (Akt, AMPK, ERK, PKG1, cyclin D-CDK) that either activate or inhibit TSC2 GAP activity, and TSC2 protein stability is controlled by the HERC1 and FBW5-DDB1-CUL4-ROC1 ubiquitin ligases, the latter antagonized by TSC1 binding; beyond mTOR regulation, TSC2 controls Rho/Rac-mediated actin cytoskeletal dynamics, cell migration, E-cadherin localization, axon guidance via EphA-ERK-Tsc2 signaling, lysosome biogenesis through RAGC-TFEB, and DNA repair enzyme OGG1 expression via NF-YA, making it a multifunctional integrator of growth factor, energy, and mechanical stress signals."},"narrative":{"mechanistic_narrative":"TSC2 (tuberin) is a multifunctional tumor suppressor that integrates growth-factor, energy, and mechanical-stress signals to restrain cell growth, principally by acting as a GTPase-activating protein (GAP) that drives GTP hydrolysis on the small GTPase Rheb and thereby suppresses mTORC1 signaling [PMID:15340059, PMID:12045200]. Its GAP activity resides in a C-terminal GAP-related domain and operates through a non-canonical catalytic 'asparagine thumb' mechanism, with TSC2 Asn1643 and Rheb Tyr35 forming the key active-site contacts defined structurally; missense mutations in this domain found in TSC patients disrupt growth control [PMID:15340059, PMID:32502382, PMID:9302281]. TSC2 functions as a stable heterodimer with TSC1 (hamartin) through reciprocal coiled-coil interactions, and TSC1 binding stabilizes TSC2 by excluding ubiquitin ligases—HERC1 and the FBW5-DDB1-CUL4-ROC1 complex—that otherwise target TSC2 for degradation [PMID:9580671, PMID:16464865, PMID:18381890, PMID:11175345]. The complex is a signaling hub controlled by direct phosphorylation: Akt, ERK, cyclin D-CDK, and PKG1 phosphorylate TSC2 at distinct sites to dissociate or destabilize the complex and tune mTORC1 output, while AMPK phosphorylation under energy stress enhances TSC2 activity [PMID:12172553, PMID:12172554, PMID:15851026, PMID:16357142, PMID:30700906, PMID:14651849]; phospho-dependent 14-3-3 binding further inhibits TSC2 function [PMID:12364343, PMID:12468542]. Reconstitution in TSC2-null cells establishes tuberin as a negative regulator of p70S6K, S6 phosphorylation, and DNA synthesis, downstream of which it controls cell size, proliferation, apoptosis, and metabolism [PMID:12045200, PMID:14651849, PMID:16702951]. Beyond Rheb-mTORC1, TSC2 governs Rho/Rac-dependent actin dynamics, cell adhesion and migration, E-cadherin localization, EphA-ERK-mediated axon guidance, lysosomal biogenesis via RAGC-TFEB, and DNA-repair enzyme OGG1 expression through NF-YA, marking it as a broad integrator of cell physiology [PMID:15611338, PMID:16388022, PMID:20813961, PMID:20062052, PMID:34253722, PMID:17989114]. Pathogenic TSC2 mutations that abolish the TSC1 interface or the GAP domain underlie tuberous sclerosis [PMID:11741833, PMID:9302281].","teleology":[{"year":1995,"claim":"Established that the TSC2 product tuberin is an enzyme—a GAP—rather than merely a structural tumor suppressor, defining its biochemical class and localizing the activity to its C-terminus.","evidence":"In vitro GTPase assays with native immunoprecipitate and recombinant C-terminal fragment, substrate specificity panel, subcellular fractionation","pmids":["7608212"],"confidence":"High","gaps":["Identified Rap1a, not Rheb, as substrate—the physiological substrate was unresolved","Did not connect GAP activity to a growth-control pathway"]},{"year":1996,"claim":"Placed tuberin at the Golgi with its then-presumed substrate Rap1, giving the first spatial context for its GAP function.","evidence":"Indirect immunofluorescence with Golgi markers and brefeldin A treatment, confocal microscopy","pmids":["8806680"],"confidence":"High","gaps":["Golgi residence not reconciled with later mTORC1/lysosomal roles","Did not address whether localization is regulated"]},{"year":1998,"claim":"Showed that the TSC1 and TSC2 products physically associate via coiled-coils, defining the heterodimeric complex that is the functional unit.","evidence":"Co-immunoprecipitation from cell lysates and coiled-coil domain mapping","pmids":["9580671"],"confidence":"High","gaps":["Functional consequence of the interaction not yet defined","Stoichiometry and complex architecture unresolved"]},{"year":2001,"claim":"Mapped the disease-relevant TSC1-binding interface on TSC2 and demonstrated that pathogenic but not benign mutations abolish complex formation, linking complex integrity to disease.","evidence":"Yeast two-hybrid and co-IP with deletion/point mutants discriminating pathogenic from polymorphic variants","pmids":["11741833"],"confidence":"High","gaps":["Did not establish downstream effector pathway","Interface defined by mutagenesis, not structure"]},{"year":2001,"claim":"Positioned TSC1-TSC2 in the insulin/PI3K/Akt growth-control pathway through Drosophila genetics, establishing the physiological signaling context.","evidence":"Drosophila epistasis and double-mutant rescue of insulin receptor lethality","pmids":["11390358"],"confidence":"High","gaps":["Molecular target downstream of TSC2 not yet identified","Direct biochemical link to Akt not shown in this work"]},{"year":2002,"claim":"Demonstrated that Akt directly phosphorylates TSC2 to destabilize the complex and relieve mTOR inhibition, defining the core growth-factor-responsive regulatory mechanism and connecting TSC2 to S6K/4E-BP1.","evidence":"In vitro kinase assays with site-directed mutagenesis (Ser924/Thr1518 in fly), co-IP, mTOR substrate and stability assays in cells and Drosophila","pmids":["12172553","12172554","12167664"],"confidence":"High","gaps":["Direct GAP substrate downstream of mTOR inhibition not yet identified as Rheb","Relative contribution of destabilization vs. complex dissociation unresolved"]},{"year":2002,"claim":"Identified phospho-dependent 14-3-3 binding as an additional inhibitory input on TSC2, showing TSC2 activity is gated by multiple Akt-regulated mechanisms.","evidence":"Yeast two-hybrid, in vitro binding, co-IP with site-specific phospho-mutants, S6K functional assays","pmids":["12364343","12468542"],"confidence":"Medium","gaps":["Single-lab studies with corroboration but no reconstitution","Quantitative contribution of 14-3-3 to physiological mTOR control unclear"]},{"year":2002,"claim":"Provided gain-of-function proof that tuberin re-expression suppresses S6/p70S6K signaling and DNA synthesis in TSC2-null cells, with rapamycin epistasis placing mTOR downstream of TSC2.","evidence":"Wild-type tuberin reconstitution in multiple TSC2-null cell lines, kinase and DNA synthesis assays, rapamycin treatment","pmids":["12045200"],"confidence":"High","gaps":["Did not define the immediate GTPase substrate linking TSC2 to mTOR"]},{"year":2003,"claim":"Showed energy stress activates TSC2 through direct AMPK phosphorylation, establishing TSC2 as the node integrating energy status with translational control and cell size.","evidence":"In vitro AMPK kinase assay, phospho-mutant rescue, cell size and apoptosis assays under energy deprivation","pmids":["14651849"],"confidence":"High","gaps":["Mechanism by which phosphorylation enhances GAP activity not resolved","Cross-talk with Akt sites not addressed"]},{"year":2004,"claim":"Identified Rheb as the physiological GAP substrate and defined the non-canonical asparagine-thumb catalytic mechanism, resolving how TSC2 controls mTORC1.","evidence":"Reconstituted in vitro GAP assays with TSC2 and Rheb mutants, cellular S6K functional validation; yeast ortholog epistasis on amino acid permeases","pmids":["15340059","14718525"],"confidence":"High","gaps":["Atomic structure of catalytic site not yet available","Role of TSC1 in catalysis vs. regulation incompletely defined"]},{"year":2005,"claim":"Established ERK as a second growth-promoting kinase that phosphorylates TSC2 to dissociate the complex, with phospho-null TSC2 suppressing tumorigenicity, linking TSC2 regulation directly to oncogenic transformation.","evidence":"In vitro ERK kinase assay, phospho-mutant expression, co-IP for complex integrity, in vivo tumor growth assay","pmids":["15851026"],"confidence":"High","gaps":["Interplay between ERK and Akt phosphorylation sites not dissected","Did not address tissue specificity of ERK input"]},{"year":2005,"claim":"Revealed an mTOR-independent role for TSC2 in actin cytoskeletal dynamics, cell adhesion, and migration through Rho/Rac regulation, broadening TSC2 function beyond growth control.","evidence":"Domain-specific (HBD/N-terminal) rescue in TSC2-null cells, Rho/Rac pull-down assays, TSC1 siRNA, migration/invasion assays; neuronal conditional knockout with LIM-kinase/cofilin readout","pmids":["15611338","16388022","16286931"],"confidence":"High","gaps":["Mechanism by which TSC2 modulates Rho/Rac GTPases not biochemically defined","Relationship between GAP-independent and GAP-dependent functions unresolved"]},{"year":2008,"claim":"Defined the ubiquitin-ligase machinery controlling TSC2 stability and showed TSC1 protects TSC2 by excluding these ligases, establishing degradation as a key regulatory layer.","evidence":"Co-IP of FBW5-DDB1-CUL4-ROC1 with TSC2, siRNA depletion, stability assays, Drosophila genetics; earlier HERC1 competitive-binding work","pmids":["18381890","16464865"],"confidence":"High","gaps":["Signals that trigger ligase-mediated TSC2 turnover not defined","Relative contribution of HERC1 vs. CUL4 ligase in vivo unclear"]},{"year":2010,"claim":"Connected TSC2 to neuronal development via EphA-ERK signaling and to epithelial integrity via E-cadherin localization, extending its role into axon guidance and EMT control.","evidence":"Tsc2+/- mouse retinogeniculate analysis with growth cone collapse assays; Tsc2-null cell E-cadherin/EMT analysis with rapamycin and CLIP170 knockdown","pmids":["20062052","20813961"],"confidence":"High","gaps":["Direct phosphorylation hierarchy in vivo only partially mapped","E-cadherin pathway dissected in single-lab cell models"]},{"year":2019,"claim":"Identified PKG1 as a stress-specific kinase phosphorylating TSC2 at S1365/S1366 to bidirectionally tune mTORC1, providing in vivo genetic proof in the heart and a therapeutically tractable regulatory node.","evidence":"In vitro PKG1 kinase assay plus phospho-null and phosphomimetic knockin mouse cardiac pressure-overload and ischemia-reperfusion models with metabolic profiling","pmids":["30700906","33401933"],"confidence":"High","gaps":["Generalizability of S1365 regulation beyond cardiac tissue not established","Mechanism by which these sites selectively affect stress-stimulated mTORC1 unresolved"]},{"year":2020,"claim":"Provided the crystal structure of the TSC2 GAP domain and a TSC2-Rheb model, validating the asparagine-thumb mechanism at atomic resolution and reinterpreting the roles of interface residues.","evidence":"X-ray crystallography, molecular dynamics simulations, pathogenic variant characterization","pmids":["32502382"],"confidence":"High","gaps":["No experimental TSC1-TSC2-Rheb holocomplex structure","Conformational regulation by phosphorylation not captured"]},{"year":2021,"claim":"Uncovered a non-canonical TSC1/2 requirement for mTORC1-mediated TFEB phosphorylation, explaining elevated lysosomal biogenesis in TSC-deficient cells through the RAGC-TFEB axis.","evidence":"TFEB phosphorylation/localization assays in TSC1/2-deficient cells, FLCN and constitutively active RAGC rescue, TSC tumor tissue analysis","pmids":["34253722"],"confidence":"Medium","gaps":["Single-lab study; mechanism by which TSC1/2 enables TFEB phosphorylation not fully defined","In vivo relevance of TFEB axis to TSC pathology incompletely established"]},{"year":null,"claim":"How the many phosphorylation inputs (Akt, ERK, AMPK, PKG1, cyclin D-CDK) are integrated combinatorially to set TSC2 GAP output in a given cell state, and how GAP-independent functions (Rho/Rac, adhesion, mitosis) are biochemically executed, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of multi-site phosphorylation integration","Biochemical basis of GAP-independent cytoskeletal and mitotic roles undefined","No structure of the regulated holocomplex with bound effectors"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,23,27]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[13,16,32]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[1,19]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[28,26]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[25,26]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[19,33]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,16,20,36]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[15,39]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[36,38]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[21,32]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[26]}],"complexes":["TSC1-TSC2 complex","DDB1-CUL4-ROC1-FBW5 ubiquitin ligase complex"],"partners":["TSC1","RHEB","AKT1","AMPK","MAPK1/ERK","PRKG1","FBW5","TACC3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49815","full_name":"Tuberin","aliases":["Tuberous sclerosis 2 protein"],"length_aa":1807,"mass_kda":200.6,"function":"Catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:33436626, PubMed:35772404). Within the TSC-TBC complex, TSC2 acts as a GTPase-activating protein (GAP) for the small GTPase RHEB, a direct activator of the protein kinase activity of mTORC1 (PubMed:12172553, PubMed:12820960, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:33436626). In absence of nutrients, the TSC-TBC complex inhibits mTORC1, thereby preventing phosphorylation of ribosomal protein S6 kinase (RPS6KB1 and RPS6KB2) and EIF4EBP1 (4E-BP1) by the mTORC1 signaling (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:35772404). The TSC-TBC complex is inactivated in response to nutrients, relieving inhibition of mTORC1 (PubMed:12172553, PubMed:24529379). Involved in microtubule-mediated protein transport via its ability to regulate mTORC1 signaling (By similarity). Also stimulates the intrinsic GTPase activity of the Ras-related proteins RAP1A and RAB5 (By similarity)","subcellular_location":"Lysosome membrane; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/P49815/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TSC2","classification":"Not Classified","n_dependent_lines":245,"n_total_lines":1208,"dependency_fraction":0.20281456953642385},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TSC2","total_profiled":1310},"omim":[{"mim_id":"619943","title":"POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 19; KCTD19","url":"https://www.omim.org/entry/619943"},{"mim_id":"618956","title":"RHEB-LIKE PROTEIN 1; RHEBL1","url":"https://www.omim.org/entry/618956"},{"mim_id":"617011","title":"MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR","url":"https://www.omim.org/entry/617011"},{"mim_id":"615869","title":"TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 1; TNFAIP8L1","url":"https://www.omim.org/entry/615869"},{"mim_id":"615730","title":"DEDICATOR OF CYTOKINESIS 7; DOCK7","url":"https://www.omim.org/entry/615730"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TSC2"},"hgnc":{"alias_symbol":["tuberin","LAM","PPP1R160"],"prev_symbol":["TSC4"]},"alphafold":{"accession":"P49815","domains":[{"cath_id":"1.25.10,1.25.40","chopping":"170-302","consensus_level":"medium","plddt":87.458,"start":170,"end":302},{"cath_id":"-","chopping":"1042-1079_1186-1213_1496-1504_1514-1533","consensus_level":"medium","plddt":78.7269,"start":1042,"end":1533},{"cath_id":"3.40.50.11210","chopping":"1541-1747","consensus_level":"high","plddt":85.7114,"start":1541,"end":1747},{"cath_id":"1.25.40","chopping":"37-157","consensus_level":"medium","plddt":86.2045,"start":37,"end":157},{"cath_id":"1.20.58","chopping":"316-419","consensus_level":"medium","plddt":88.6087,"start":316,"end":419}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49815","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49815-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49815-F1-predicted_aligned_error_v6.png","plddt_mean":67.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TSC2","jax_strain_url":"https://www.jax.org/strain/search?query=TSC2"},"sequence":{"accession":"P49815","fasta_url":"https://rest.uniprot.org/uniprotkb/P49815.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49815/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49815"}},"corpus_meta":[{"pmid":"14651849","id":"PMC_14651849","title":"TSC2 mediates cellular energy response to control cell growth and survival.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/14651849","citation_count":3191,"is_preprint":false},{"pmid":"12172553","id":"PMC_12172553","title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.","date":"2002","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12172553","citation_count":2524,"is_preprint":false},{"pmid":"15851026","id":"PMC_15851026","title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15851026","citation_count":1071,"is_preprint":false},{"pmid":"18466115","id":"PMC_18466115","title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18466115","citation_count":1001,"is_preprint":false},{"pmid":"12172554","id":"PMC_12172554","title":"Akt regulates growth by directly phosphorylating Tsc2.","date":"2002","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12172554","citation_count":783,"is_preprint":false},{"pmid":"19143635","id":"PMC_19143635","title":"A complex interplay between Akt, TSC2 and the two mTOR complexes.","date":"2009","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/19143635","citation_count":595,"is_preprint":false},{"pmid":"12957289","id":"PMC_12957289","title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways.","date":"2003","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/12957289","citation_count":456,"is_preprint":false},{"pmid":"9580671","id":"PMC_9580671","title":"Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9580671","citation_count":438,"is_preprint":false},{"pmid":"16286931","id":"PMC_16286931","title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.","date":"2005","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16286931","citation_count":393,"is_preprint":false},{"pmid":"11390358","id":"PMC_11390358","title":"TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11390358","citation_count":380,"is_preprint":false},{"pmid":"12045200","id":"PMC_12045200","title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12045200","citation_count":368,"is_preprint":false},{"pmid":"14729330","id":"PMC_14729330","title":"TSC2: filling the GAP in the mTOR signaling pathway.","date":"2004","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/14729330","citation_count":342,"is_preprint":false},{"pmid":"7608212","id":"PMC_7608212","title":"Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7608212","citation_count":324,"is_preprint":false},{"pmid":"12167664","id":"PMC_12167664","title":"Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12167664","citation_count":312,"is_preprint":false},{"pmid":"14614311","id":"PMC_14614311","title":"Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.","date":"2003","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/14614311","citation_count":271,"is_preprint":false},{"pmid":"15340059","id":"PMC_15340059","title":"Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15340059","citation_count":208,"is_preprint":false},{"pmid":"11175345","id":"PMC_11175345","title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11175345","citation_count":204,"is_preprint":false},{"pmid":"20062052","id":"PMC_20062052","title":"Tsc2-Rheb signaling regulates EphA-mediated axon guidance.","date":"2010","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20062052","citation_count":198,"is_preprint":false},{"pmid":"16464865","id":"PMC_16464865","title":"TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16464865","citation_count":186,"is_preprint":false},{"pmid":"28215400","id":"PMC_28215400","title":"Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.","date":"2017","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28215400","citation_count":158,"is_preprint":false},{"pmid":"16627617","id":"PMC_16627617","title":"TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16627617","citation_count":149,"is_preprint":false},{"pmid":"18381890","id":"PMC_18381890","title":"WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase.","date":"2008","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/18381890","citation_count":142,"is_preprint":false},{"pmid":"11829138","id":"PMC_11829138","title":"Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.","date":"2002","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11829138","citation_count":115,"is_preprint":false},{"pmid":"9302281","id":"PMC_9302281","title":"The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9302281","citation_count":115,"is_preprint":false},{"pmid":"30700906","id":"PMC_30700906","title":"PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30700906","citation_count":114,"is_preprint":false},{"pmid":"21482669","id":"PMC_21482669","title":"mTORC2 is required for proliferation and survival of TSC2-null cells.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21482669","citation_count":109,"is_preprint":false},{"pmid":"12781866","id":"PMC_12781866","title":"Tumour suppressors hamartin and tuberin: intracellular signalling.","date":"2003","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/12781866","citation_count":105,"is_preprint":false},{"pmid":"18291711","id":"PMC_18291711","title":"The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners.","date":"2008","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/18291711","citation_count":103,"is_preprint":false},{"pmid":"16959613","id":"PMC_16959613","title":"Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.","date":"2006","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/16959613","citation_count":103,"is_preprint":false},{"pmid":"8806680","id":"PMC_8806680","title":"Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8806680","citation_count":94,"is_preprint":false},{"pmid":"15611338","id":"PMC_15611338","title":"TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15611338","citation_count":93,"is_preprint":false},{"pmid":"12364343","id":"PMC_12364343","title":"Regulation of TSC2 by 14-3-3 binding.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12364343","citation_count":93,"is_preprint":false},{"pmid":"11741833","id":"PMC_11741833","title":"Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11741833","citation_count":92,"is_preprint":false},{"pmid":"21329690","id":"PMC_21329690","title":"TSC1/TSC2 signaling in the CNS.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21329690","citation_count":87,"is_preprint":false},{"pmid":"14718525","id":"PMC_14718525","title":"Tsc1+ and tsc2+ regulate arginine uptake and metabolism in Schizosaccharomyces pombe.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14718525","citation_count":86,"is_preprint":false},{"pmid":"32912901","id":"PMC_32912901","title":"AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.","date":"2020","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/32912901","citation_count":86,"is_preprint":false},{"pmid":"18032745","id":"PMC_18032745","title":"Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.","date":"2007","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18032745","citation_count":82,"is_preprint":false},{"pmid":"11290735","id":"PMC_11290735","title":"Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11290735","citation_count":82,"is_preprint":false},{"pmid":"10504485","id":"PMC_10504485","title":"Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue.","date":"1999","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/10504485","citation_count":81,"is_preprint":false},{"pmid":"34253722","id":"PMC_34253722","title":"TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34253722","citation_count":81,"is_preprint":false},{"pmid":"15150271","id":"PMC_15150271","title":"Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15150271","citation_count":81,"is_preprint":false},{"pmid":"9006320","id":"PMC_9006320","title":"Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.","date":"1997","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9006320","citation_count":70,"is_preprint":false},{"pmid":"14559897","id":"PMC_14559897","title":"Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14559897","citation_count":70,"is_preprint":false},{"pmid":"12468542","id":"PMC_12468542","title":"14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12468542","citation_count":67,"is_preprint":false},{"pmid":"16357142","id":"PMC_16357142","title":"Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16357142","citation_count":66,"is_preprint":false},{"pmid":"12176984","id":"PMC_12176984","title":"Identification and characterization of the interaction between tuberin and 14-3-3zeta.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12176984","citation_count":65,"is_preprint":false},{"pmid":"16388022","id":"PMC_16388022","title":"Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.","date":"2005","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16388022","citation_count":64,"is_preprint":false},{"pmid":"16206276","id":"PMC_16206276","title":"Hamartin and tuberin: working together for tumour suppression.","date":"2006","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16206276","citation_count":63,"is_preprint":false},{"pmid":"25654764","id":"PMC_25654764","title":"TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25654764","citation_count":60,"is_preprint":false},{"pmid":"19419980","id":"PMC_19419980","title":"TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19419980","citation_count":60,"is_preprint":false},{"pmid":"24395886","id":"PMC_24395886","title":"Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24395886","citation_count":60,"is_preprint":false},{"pmid":"9989450","id":"PMC_9989450","title":"Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.","date":"1999","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/9989450","citation_count":60,"is_preprint":false},{"pmid":"11437991","id":"PMC_11437991","title":"Mutational analysis of TSC1 and TSC2 genes in gangliogliomas.","date":"2001","source":"Neuropathology and applied neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/11437991","citation_count":59,"is_preprint":false},{"pmid":"7558029","id":"PMC_7558029","title":"Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7558029","citation_count":55,"is_preprint":false},{"pmid":"21419848","id":"PMC_21419848","title":"Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration.","date":"2011","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/21419848","citation_count":54,"is_preprint":false},{"pmid":"20813961","id":"PMC_20813961","title":"Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition.","date":"2010","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20813961","citation_count":53,"is_preprint":false},{"pmid":"16862180","id":"PMC_16862180","title":"Akt regulates nuclear/cytoplasmic localization of tuberin.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16862180","citation_count":52,"is_preprint":false},{"pmid":"24591652","id":"PMC_24591652","title":"Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24591652","citation_count":51,"is_preprint":false},{"pmid":"20959633","id":"PMC_20959633","title":"Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin.","date":"2010","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/20959633","citation_count":47,"is_preprint":false},{"pmid":"11266527","id":"PMC_11266527","title":"Hamartin and tuberin expression in human tissues.","date":"2001","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/11266527","citation_count":45,"is_preprint":false},{"pmid":"16702951","id":"PMC_16702951","title":"Tuberin activates the proapoptotic molecule BAD.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16702951","citation_count":44,"is_preprint":false},{"pmid":"31676321","id":"PMC_31676321","title":"Alpinetin improves intestinal barrier homeostasis via regulating AhR/suv39h1/TSC2/mTORC1/autophagy pathway.","date":"2019","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31676321","citation_count":43,"is_preprint":false},{"pmid":"33401933","id":"PMC_33401933","title":"MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.","date":"2021","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/33401933","citation_count":42,"is_preprint":false},{"pmid":"11880313","id":"PMC_11880313","title":"Phosphatidylinositol 3-kinase but not tuberin is required for PDGF-induced cell migration.","date":"2002","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11880313","citation_count":40,"is_preprint":false},{"pmid":"29396625","id":"PMC_29396625","title":"TSC1 and TSC2 regulate cilia length and canonical Hedgehog signaling via different mechanisms.","date":"2018","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/29396625","citation_count":39,"is_preprint":false},{"pmid":"15093748","id":"PMC_15093748","title":"Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport.","date":"2004","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15093748","citation_count":38,"is_preprint":false},{"pmid":"24797175","id":"PMC_24797175","title":"Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24797175","citation_count":38,"is_preprint":false},{"pmid":"9444353","id":"PMC_9444353","title":"Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis.","date":"1997","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/9444353","citation_count":35,"is_preprint":false},{"pmid":"9266734","id":"PMC_9266734","title":"Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.","date":"1997","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9266734","citation_count":35,"is_preprint":false},{"pmid":"35093450","id":"PMC_35093450","title":"Quercetin mediates TSC2-RHEB-mTOR pathway to regulate chondrocytes autophagy in knee osteoarthritis.","date":"2022","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/35093450","citation_count":34,"is_preprint":false},{"pmid":"20237422","id":"PMC_20237422","title":"TACC3-TSC2 maintains nuclear envelope structure and controls cell division.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20237422","citation_count":34,"is_preprint":false},{"pmid":"27860187","id":"PMC_27860187","title":"Autophagy activated by tuberin/mTOR/p70S6K suppression is a protective mechanism against local anaesthetics neurotoxicity.","date":"2016","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27860187","citation_count":34,"is_preprint":false},{"pmid":"12147258","id":"PMC_12147258","title":"Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin.","date":"2002","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/12147258","citation_count":33,"is_preprint":false},{"pmid":"10805093","id":"PMC_10805093","title":"Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.","date":"2000","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/10805093","citation_count":32,"is_preprint":false},{"pmid":"11553313","id":"PMC_11553313","title":"Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis.","date":"2001","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11553313","citation_count":32,"is_preprint":false},{"pmid":"17989114","id":"PMC_17989114","title":"Tuberin regulates the DNA repair enzyme OGG1.","date":"2007","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17989114","citation_count":31,"is_preprint":false},{"pmid":"10807585","id":"PMC_10807585","title":"Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney.","date":"2000","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10807585","citation_count":31,"is_preprint":false},{"pmid":"8954784","id":"PMC_8954784","title":"The tuberin (TSC2), autosomal dominant polycystic kidney disease (PKD1), and somatostatin type V receptor (SSTR5) genes form a synteny group in the Fugu genome.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8954784","citation_count":30,"is_preprint":false},{"pmid":"15963462","id":"PMC_15963462","title":"Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15963462","citation_count":30,"is_preprint":false},{"pmid":"19250671","id":"PMC_19250671","title":"Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia.","date":"2009","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/19250671","citation_count":29,"is_preprint":false},{"pmid":"33742095","id":"PMC_33742095","title":"Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation.","date":"2021","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/33742095","citation_count":29,"is_preprint":false},{"pmid":"28973543","id":"PMC_28973543","title":"Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28973543","citation_count":27,"is_preprint":false},{"pmid":"32502382","id":"PMC_32502382","title":"Structure of the TSC2 GAP Domain: Mechanistic Insight into Catalysis and Pathogenic Mutations.","date":"2020","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/32502382","citation_count":27,"is_preprint":false},{"pmid":"20235888","id":"PMC_20235888","title":"Lymphangioleiomyomatosis and TSC2-/- cells.","date":"2010","source":"Lymphatic research and biology","url":"https://pubmed.ncbi.nlm.nih.gov/20235888","citation_count":25,"is_preprint":false},{"pmid":"18854862","id":"PMC_18854862","title":"A reliable cell-based assay for testing unclassified TSC2 gene variants.","date":"2008","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/18854862","citation_count":25,"is_preprint":false},{"pmid":"27409169","id":"PMC_27409169","title":"VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27409169","citation_count":25,"is_preprint":false},{"pmid":"8634701","id":"PMC_8634701","title":"Mutation analysis of the TSC2 gene in an African-American family.","date":"1995","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8634701","citation_count":25,"is_preprint":false},{"pmid":"11307618","id":"PMC_11307618","title":"Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.","date":"2001","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/11307618","citation_count":25,"is_preprint":false},{"pmid":"27640314","id":"PMC_27640314","title":"Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.","date":"2016","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/27640314","citation_count":24,"is_preprint":false},{"pmid":"34544857","id":"PMC_34544857","title":"Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34544857","citation_count":23,"is_preprint":false},{"pmid":"27984090","id":"PMC_27984090","title":"RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death.","date":"2016","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27984090","citation_count":23,"is_preprint":false},{"pmid":"36473049","id":"PMC_36473049","title":"Cross-talk between TSC2 and the extracellular matrix controls pulmonary vascular proliferation and pulmonary hypertension.","date":"2022","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/36473049","citation_count":23,"is_preprint":false},{"pmid":"32045362","id":"PMC_32045362","title":"Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth.","date":"2020","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32045362","citation_count":23,"is_preprint":false},{"pmid":"23749404","id":"PMC_23749404","title":"Comparative analysis of Tsc1 and Tsc2 single and double radial glial cell mutants.","date":"2013","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23749404","citation_count":23,"is_preprint":false},{"pmid":"29966750","id":"PMC_29966750","title":"Autophagy mediators (FOXO1, SESN3 and TSC2) in Lewy body disease and aging.","date":"2018","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/29966750","citation_count":22,"is_preprint":false},{"pmid":"19648120","id":"PMC_19648120","title":"TSC2 deficiency increases PTEN via HIF1alpha.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19648120","citation_count":22,"is_preprint":false},{"pmid":"23359422","id":"PMC_23359422","title":"Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells.","date":"2013","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/23359422","citation_count":22,"is_preprint":false},{"pmid":"16552619","id":"PMC_16552619","title":"Hamartin and tuberin modulate gene transcription via beta-catenin.","date":"2006","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16552619","citation_count":21,"is_preprint":false},{"pmid":"37251941","id":"PMC_37251941","title":"The role of TSC2 in breast cancer: a literature review.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37251941","citation_count":20,"is_preprint":false},{"pmid":"20042714","id":"PMC_20042714","title":"The loss of tuberin promotes cell invasion through the ß-catenin pathway.","date":"2009","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20042714","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47781,"output_tokens":10757,"usd":0.152349,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21504,"output_tokens":5750,"usd":0.125635,"stage2_stop_reason":"end_turn"},"total_usd":0.277984,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"TSC2 protein product tuberin (180 kDa) exhibits specific GTPase-activating protein (GAP) activity towards Rap1a in vitro, stimulating its intrinsic GTPase activity; this activity resides in the C-terminal fragment of tuberin. Tuberin did not stimulate GTPase activity of Rap2, Ha-Ras, Rac, or Rho. Subcellular fractionation revealed that most tuberin resides in a membrane/particulate (100,000×g) fraction.\",\n      \"method\": \"Immunoprecipitation of native tuberin followed by GTPase activity assay; bacterially and Sf9-expressed C-terminal fragment assays; subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic assay with recombinant protein, confirmed with native immunoprecipitate, substrate specificity panel included\",\n      \"pmids\": [\"7608212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Tuberin co-localizes with its substrate Rap1 in the Golgi apparatus of cultured cells, as demonstrated by co-localization with Golgi markers (mannosidase-II, furin) and disruption by brefeldin A treatment; tuberin shows punctate, perinuclear staining consistent with Golgi localization.\",\n      \"method\": \"Indirect immunofluorescence, double immunofluorescence with Golgi markers, brefeldin A treatment, confocal microscopy\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct subcellular localization with multiple orthogonal markers and pharmacological validation, replicated by co-localization with substrate\",\n      \"pmids\": [\"8806680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The GAP-related domain of tuberin (encoded by exons 34–38, ~160 amino acids) is a key functional region; missense mutations within this domain (in exons 36, 37, 38) identified in TSC patients disrupt tuberin's growth-regulatory function, confirming the GAP domain's critical role.\",\n      \"method\": \"SSCP mutation analysis, direct sequencing, de novo mutation confirmation in sporadic cases\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — mutation mapping without direct biochemical reconstitution, but multiple independent patient cases converge on same domain\",\n      \"pmids\": [\"9302281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hamartin (TSC1 product) and tuberin (TSC2 product) physically interact in vivo, forming a complex; the interaction is mediated by predicted coiled-coil domains in each protein.\",\n      \"method\": \"Co-immunoprecipitation from cell lysates, coiled-coil domain prediction and mapping\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP demonstrated in vivo, domain mapping included, independently replicated by multiple subsequent labs\",\n      \"pmids\": [\"9580671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hamartin stabilizes tuberin by inhibiting its ubiquitination; tuberin is highly ubiquitinated in cells, but the fraction bound to hamartin is not ubiquitinated. Co-expression of TSC1 with TSC2 results in higher tuberin levels. The amino-terminal two-thirds of tuberin mediate its ubiquitination and hamartin stabilization.\",\n      \"method\": \"Transient transfection, co-immunoprecipitation, ubiquitination assay, domain deletion analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct ubiquitination assay, domain mapping, disease mutant comparison, multiple orthogonal methods\",\n      \"pmids\": [\"11175345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TSC1 and TSC2 form a complex and function in a common pathway to control cellular growth; genetic analyses in Drosophila place the TSC genes in a pathway parallel to but converging downstream of Akt in insulin/PI3K signaling; TSC1 or TSC2 heterozygosity rescues lethality of loss-of-function insulin receptor mutants.\",\n      \"method\": \"Drosophila genetics, epistasis analysis, double-mutant rescue experiments\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in Drosophila with multiple allele combinations, pathway placement confirmed by suppressor analysis\",\n      \"pmids\": [\"11390358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Tuberin is phosphorylated at serine and tyrosine residues in response to serum and other factors. Disease-related TSC2 mutations (Y1571H, P1675L) reduce tuberin phosphorylation, disrupt TSC1-TSC2 interaction, and curtail tuberin's growth inhibitory activity, demonstrating that phosphorylation regulates TSC1-TSC2 complex formation and function.\",\n      \"method\": \"Immunoprecipitation, phosphorylation assays, co-immunoprecipitation with disease mutants, overexpression growth assays in COS1 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphorylation assays with disease mutant comparison, co-IP, functional growth assay; single lab\",\n      \"pmids\": [\"11290735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Pathological mutations in TSC1 (N198_F199delinsI; 593-595delACT) and TSC2 (G294E, I365del) that lie within the binding interface abolish or dramatically reduce hamartin-tuberin interaction. The hamartin-binding domain maps to tuberin amino acids 1–418 (requiring a coiled-coil at aa 346–371 plus N-terminal residues); non-pathogenic polymorphisms at adjacent positions do not disrupt binding.\",\n      \"method\": \"Yeast two-hybrid with deletion/point mutant constructs, co-immunoprecipitation from COS7 cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two orthogonal systems (yeast two-hybrid + co-IP), disease vs. benign mutant discrimination, domain boundaries defined\",\n      \"pmids\": [\"11741833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TSC2 is directly phosphorylated by Akt at multiple sites; Akt-dependent phosphorylation destabilizes TSC2 and disrupts its interaction with TSC1, thereby relieving TSC1-TSC2 inhibition of mTOR. TSC1-TSC2 inhibits S6K1 and activates 4E-BP1 through inhibition of mTOR.\",\n      \"method\": \"In vitro kinase assay (direct phosphorylation), co-immunoprecipitation, S6K and 4E-BP1 phosphorylation assays, TSC2 stability assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro kinase assay plus cellular mechanistic follow-up with multiple substrates, independently replicated\",\n      \"pmids\": [\"12172553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Drosophila Akt/PKB directly phosphorylates Tsc2 in vitro at conserved residues Ser924 and Thr1518; mutation of these sites renders Tsc2 insensitive to Akt signaling, increases stability of the Tsc1-Tsc2 complex, and blocks all Akt-dependent growth signals in vivo.\",\n      \"method\": \"In vitro kinase assay with recombinant Akt, site-directed mutagenesis, Drosophila genetics, co-immunoprecipitation, cell size measurements\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro phosphorylation with mutagenesis confirming specific sites, in vivo genetic rescue, independently replicated\",\n      \"pmids\": [\"12172554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PI3K/Akt pathway phosphorylates tuberin in response to insulin/IGF-1; Akt associates with hamartin-tuberin complexes and promotes tuberin phosphorylation and increased degradation of hamartin-tuberin complexes. Akt-phosphorylated tuberin loses ability to inhibit CDK2 activity via p27(kip1) degradation suppression.\",\n      \"method\": \"Co-immunoprecipitation, kinase assays with constitutively active PI3K/Akt constructs, PI3K inhibitor LY294002, p27 stability assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods, constitutively active and inhibitor approaches, confirmed in multiple labs\",\n      \"pmids\": [\"12167664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Tuberin associates with 14-3-3 proteins in vivo; phosphorylation of Ser1210 in TSC2 is required for this interaction. 14-3-3 association inhibits TSC2 function (mTOR pathway inhibition); 14-3-3 interaction is regulated by Akt-mediated phosphorylation of tuberin.\",\n      \"method\": \"Co-immunoprecipitation, phospho-mutant analysis, S6K phosphorylation functional assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with site-specific mutant, functional assay; single lab, confirmed by parallel 14-3-3zeta study\",\n      \"pmids\": [\"12364343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"14-3-3zeta binds tuberin at multiple sites in an Akt-phosphorylation-regulated manner; 14-3-3zeta can form a ternary complex with TSC1-TSC2 without interfering with TSC1-TSC2 binding. Overexpression of 14-3-3beta antagonizes TSC1-TSC2 inhibition of S6K phosphorylation in a TSC2-interaction-dependent manner.\",\n      \"method\": \"Yeast two-hybrid screening, in vitro binding assay, co-immunoprecipitation, S6K phosphorylation assay with mutant TSC2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus functional assay; single lab, corroborated by parallel Li et al. 2002 study\",\n      \"pmids\": [\"12468542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Tuberin re-expression in TSC2-null LAM-derived and ELT3 cells abolishes hyperphosphorylation of ribosomal protein S6 and significantly inhibits p70S6K activity and DNA synthesis, establishing tuberin as a specific negative regulator of S6/p70S6K. Rapamycin mimics this effect, placing mTOR downstream of tuberin.\",\n      \"method\": \"Re-expression of wild-type tuberin in TSC2-null cell lines, p70S6K activity assay, S6 phosphorylation by immunoblot, DNA synthesis assay, rapamycin treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function/gain-of-function reconstitution in multiple TSC2-null cell lines, multiple orthogonal readouts\",\n      \"pmids\": [\"12045200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TSC2 regulates HIF-1alpha levels and VEGF expression through both mTOR-dependent and mTOR-independent pathways. Loss of TSC2 results in HIF-1alpha accumulation and increased VEGF; rapamycin normalizes HIF but only partially reduces VEGF, indicating an additional mTOR-independent chromatin remodeling pathway.\",\n      \"method\": \"TSC2-null cell analysis, rapamycin treatment, HDAC inhibitor trichostatin A treatment, HIF-1alpha and VEGF reporter assays\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection of two pathways, wild-type vs. disease-mutant TSC2 rescue; single lab\",\n      \"pmids\": [\"12957289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Under energy starvation, AMPK directly phosphorylates TSC2 and enhances its activity. This AMPK-mediated phosphorylation of TSC2 is required for translational regulation and cell size control in response to energy deprivation, and protects cells from energy deprivation-induced apoptosis.\",\n      \"method\": \"In vitro kinase assay (AMPK phosphorylates TSC2), phospho-mutant rescue experiments, cell size measurements, apoptosis assays under energy starvation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro kinase assay, phospho-mutant loss-of-function, multiple cellular phenotype readouts, replicated by subsequent studies\",\n      \"pmids\": [\"14651849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TSC2 has GAP activity specifically towards the small GTPase Rheb (not using the canonical arginine finger mechanism), instead employing a catalytic 'asparagine thumb'; Asn residues in TSC2 are essential for GAP activity. Rheb Arg15 (equivalent to Gly12 in Ras) is important for TSC2-stimulated hydrolysis. TSC1 is not required for TSC2 GAP activity but may serve as a regulatory component.\",\n      \"method\": \"In vitro GTPase assay with recombinant proteins, site-directed mutagenesis of TSC2 and Rheb, S6K phosphorylation functional assay, TSC1-binding defective mutant analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro GAP assay with mutagenesis defining catalytic mechanism, cellular functional validation\",\n      \"pmids\": [\"15340059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TSC2 modulates actin dynamics and cell adhesion through its TSC1-binding domain (TSC2-HBD); expression of TSC2 or TSC2-HBD in TSC2-null cells promotes Rac1 activation, inhibition of RhoA, stress fiber disassembly, and focal adhesion remodeling. TSC1 inhibits Rac1, and TSC2 blocks this TSC1 activity.\",\n      \"method\": \"Re-expression of TSC2 and deletion constructs in TSC2-null cells, Rho/Rac pull-down activity assays, TSC1 siRNA knockdown, immunofluorescence of actin/focal adhesions\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain-specific rescue, GTPase activity assays, siRNA knockdown, multiple orthogonal readouts\",\n      \"pmids\": [\"15611338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tuberin (TSC2) expression increases B-Raf kinase activity and p42/44 MAPK phosphorylation via an mTOR-independent mechanism. Rheb (TSC2 GAP substrate) inhibits wild-type but not activated B-Raf, and interacts with endogenous B-Raf; B-Raf inhibition by Rheb is rapamycin-resistant, dissociable from S6K activation.\",\n      \"method\": \"TSC2 siRNA knockdown, B-Raf kinase assay, co-immunoprecipitation of Rheb and B-Raf, rapamycin treatment, farnesylation-defective Rheb mutant\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct kinase assay, co-IP, genetic dissection; single lab, mTOR-independence confirmed pharmacologically\",\n      \"pmids\": [\"15150271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tuberin is a component of lipid rafts and co-fractionates with caveolin-1 in low-density Triton X-100-resistant fractions; tuberin regulates caveolin-1 localization to the plasma membrane and caveolae formation. Loss of tuberin displaces caveolin-1 to a post-Golgi compartment; TSC2 re-expression reverses this. TSC2 also regulates post-Golgi vesicle transport (VSVG-GFP trafficking).\",\n      \"method\": \"Sucrose gradient fractionation, immunofluorescence, BFA-sensitive compartment analysis, Tsc2-/- cell re-expression, VSVG-GFP trafficking assay\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical fractionation plus functional rescue with wild-type vs. disease mutant, VSVG trafficking assay; single lab\",\n      \"pmids\": [\"15093748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Erk directly phosphorylates TSC2, leading to TSC1-TSC2 complex dissociation and markedly impaired TSC2 ability to inhibit mTOR signaling, cell proliferation, and oncogenic transformation. Expression of an Erk non-phosphorylatable TSC2 mutant in TSC2+/- tumor cells blocks tumorigenicity in vivo, while wild-type TSC2 is ineffective.\",\n      \"method\": \"In vitro kinase assay (Erk phosphorylates TSC2), phospho-mutant expression, co-immunoprecipitation for complex integrity, mTOR substrate assays, in vivo tumor growth assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro kinase assay, mutagenesis, in vivo tumor suppression validation with phospho-null mutant\",\n      \"pmids\": [\"15851026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Loss of Tsc1 or Tsc2 in hippocampal neurons triggers enlargement of somas and dendritic spines and alters glutamatergic synapse properties. Morphological changes require regulation of cofilin via LIM-kinase phosphorylation, which is increased by loss of Tsc2, placing TSC2 upstream of the LIM-kinase/cofilin actin regulatory pathway in neurons.\",\n      \"method\": \"Conditional knockout mouse neurons (CA1 pyramidal cells), spine size imaging, electrophysiology, LIM-kinase phospho-cofilin western blotting, rescue experiments\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function in neurons with defined phenotype (morphology + electrophysiology), pathway mechanism identified (cofilin phosphorylation)\",\n      \"pmids\": [\"16286931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TSC2 is a cyclin D binding protein; coexpression of cyclin D1-CDK4/6 leads to increased TSC2 phosphorylation and decreased levels of both TSC2 and TSC1 proteins, promoting mTOR substrate phosphorylation (4E-BP1, S6K1). Cyclin D1 can regulate TSC1-TSC2 independently of CDK4/6 catalytic activity.\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation assays, TSC protein level measurements, CDK inhibitor and kinase-dead CDK6, mTOR substrate phosphorylation, cell size assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, biochemical and functional assays, CDK-independent mechanism demonstrated; single lab\",\n      \"pmids\": [\"16357142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TSC1 stabilizes TSC2 by excluding the HERC1 ubiquitin ligase (a 532-kDa HECT-domain E3) from the TSC2 complex; disease mutations in TSC2 that result in protein destabilization allow HERC1 binding even in the presence of TSC1, revealing a mechanism by which TSC1 protects TSC2 from ubiquitin-mediated degradation.\",\n      \"method\": \"Co-immunoprecipitation identifying HERC1 as TSC2-interacting protein, competitive binding assay with TSC1, disease mutant analysis, TSC2 stability measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of endogenous proteins, competitive binding, disease mutant mechanistic insight; single lab\",\n      \"pmids\": [\"16464865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TSC1/TSC2 complex has negative and positive effects on TORC1 and TORC2 respectively. In Drosophila S2 cells, Rheb (TSC2's GAP substrate) inhibits dTORC2 activity via a dTORC1/dS6K feedback mechanism. In human cells, TSC1/2 positively affects TORC2 activity (measured by Akt-Ser473 phosphorylation).\",\n      \"method\": \"S6K and Akt phosphorylation assays as functional readouts for TORC1/2 in Drosophila S2 cells and HEK293 cells, siRNA knockdown\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays in two cell systems, mechanistic feedback identified; single lab\",\n      \"pmids\": [\"16627617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Akt phosphorylation of tuberin triggers cytoplasmic retention of tuberin (downregulation of nuclear tuberin). In arrested G0 cells with low Akt activity, significant tuberin fraction localizes to the nucleus. Tuberin retains ability to regulate p70S6K in both cytoplasm and nucleus independently of mTOR/p70S6K regulation of p27.\",\n      \"method\": \"Nuclear/cytoplasmic fractionation, immunofluorescence, Akt inhibition and activation, cell cycle synchronization (G0 arrest)\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — fractionation plus immunofluorescence, Akt activity correlation; single lab, functional link to p70S6K demonstrated\",\n      \"pmids\": [\"16862180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tuberin triggers apoptosis via a pathway involving downregulation of p70S6K, reduction of BAD Ser136 phosphorylation, and upregulation of BAD/BCL-2 and BAD/BCL-XL interactions. BAD-knockout cells establish BAD as a required mediator of tuberin's pro-apoptotic effects. AKT phosphorylation negatively regulates tuberin's ability to trigger apoptosis.\",\n      \"method\": \"Tuberin overexpression, BAD-/- MEFs, co-immunoprecipitation of BAD/BCL-2/BCL-XL, p70S6K and BAD phosphorylation assays, apoptosis measurements\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (BAD-KO cells) plus biochemical pathway dissection; single lab\",\n      \"pmids\": [\"16702951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"FBW5, a DDB1-binding WD40 protein, recruits TSC2 to the DDB1-CUL4-ROC1 E3 ubiquitin ligase complex to promote TSC2 ubiquitination and degradation. Overexpression of FBW5 or CUL4A promotes TSC2 degradation, which is abrogated by TSC1 co-expression. Depletion of FBW5, DDB1, or CUL4A/B stabilizes TSC2. Drosophila Ddb1/Cul4 mutations cause Gigas/TSC2 accumulation.\",\n      \"method\": \"Co-immunoprecipitation (FBW5-TSC2-DDB1-CUL4-ROC1), siRNA knockdown, TSC2 stability assays, Drosophila genetic analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biochemical complex reconstitution, siRNA depletion, overexpression, and in vivo Drosophila genetic validation; multiple orthogonal approaches\",\n      \"pmids\": [\"18381890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hamartin and tuberin are multicompartmental proteins found in cytosolic, microsomal, and cytoskeletal fractions where they form a stable complex. Within the microsomal fraction they behave as peripheral membrane proteins. Immunoisolation of tuberin-bound vesicles shows enrichment of Rap1, Rab5, and caveolin-1.\",\n      \"method\": \"Cell fractionation, co-immunoprecipitation in each fraction, immunoisolation with magnetic beads, colocalization immunofluorescence\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical fractionation with co-IP in each compartment, immunoisolation; single lab\",\n      \"pmids\": [\"12147258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cell migration and invasiveness of LAM cells is increased and is abolished by TSC2 re-expression. TSC2 inhibits cell migration through its N-terminus (independent of GAP activity) by associating with TSC1 and regulating RhoA activity; RhoA is activated in LAM cells and its pharmacological inhibition abolishes LAM cell migration.\",\n      \"method\": \"Migration and invasion assays, TSC2 re-expression, N-terminal domain constructs, TSC1 siRNA knockdown, RhoA pull-down activity assay, Rho inhibitor pharmacology\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-specific reconstitution, RhoA activity assay, siRNA, pharmacological inhibition; single lab\",\n      \"pmids\": [\"16388022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Tuberin regulates expression of the DNA repair enzyme OGG1 via the transcription factor NF-YA; TSC2-null cells have markedly decreased OGG1 mRNA, protein and activity, accumulate 8-oxodG, and show reduced NF-YA binding to the OGG1 promoter. Re-introduction of TSC2 cDNA into tuberin-deficient cells restores NF-YA and OGG1 expression.\",\n      \"method\": \"siRNA knockdown of TSC2, TSC2-null MEFs (TSC2-/- and +/-), ChIP, EMSA (gel shift), OGG1 promoter reporter assay, TSC2 cDNA rescue\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple TSC2 loss models, ChIP, promoter reporter, and rescue; single lab\",\n      \"pmids\": [\"17989114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Tsc2-null cells lacking TSC2 have attenuated mTORC2 activity. mTORC2 (via rictor) modulates TSC2-null cell proliferation and survival through RhoA GTPase and Bcl2 proteins. Constitutively active V14RhoA reverses growth inhibition induced by rictor siRNA or TSC2 re-expression, placing RhoA downstream of mTORC2 in TSC2-null cells.\",\n      \"method\": \"siRNA knockdown of mTOR pathway components (raptor, rictor, Rheb), constitutively active RhoA rescue, apoptosis assays, RhoA pull-down, in vivo tumor growth\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic pathway dissection via siRNA, constitutively active rescue, in vivo validation; single lab\",\n      \"pmids\": [\"21482669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Tsc2 haploinsufficiency in mice causes aberrant retinogeniculate projections (EphA-dependent axon guidance defects). EphA receptor activation by ephrin-A ligands inhibits ERK1/2 and decreases ERK1/2-mediated inhibition of Tsc2, thereby inactivating the mTOR pathway. Tsc2 deficiency and hyperactive Rheb constitutively activate mTOR and inhibit ephrin-induced growth cone collapse.\",\n      \"method\": \"Tsc2+/- mouse retinogeniculate projection analysis, ephrin-A stimulation, ERK1/2 and Tsc2 phosphorylation assays, growth cone collapse assay, constitutively active Rheb expression\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo mouse model plus cellular mechanistic dissection, kinase pathway hierarchy defined, multiple orthogonal assays\",\n      \"pmids\": [\"20062052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Tuberin regulates E-cadherin localization to the plasma membrane via an Akt/mTORC1/CLIP170-dependent, rapamycin-sensitive pathway; Tsc2-null cells display loss of plasma membrane E-cadherin leading to reduced cell-cell adhesion, EMT markers (loss of E-cadherin/occludin, gain of Snail/SMA), and anchorage-independent growth.\",\n      \"method\": \"Tsc2-/- cell analysis, rapamycin treatment, CLIP170 knockdown, E-cadherin localization by immunofluorescence, EMT marker western blots, anoikis assay\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway (Akt/mTORC1/CLIP170) dissected pharmacologically, multiple cellular phenotypes; single lab\",\n      \"pmids\": [\"20813961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TACC3 physically interacts with TSC2; they co-localize and co-purify with nuclear envelope components. TACC3 is required for proper localization of phospho-Ser939 TSC2 at spindle poles and cytokinetic bridges. Tsc2-deficient cells show abscission defects and increased binucleated cells; TSC2 acts epistatically to TACC3 in regulating cell division.\",\n      \"method\": \"TACC3 interactome mapping (co-IP/MS), co-localization microscopy, Tsc2/Tacc3 siRNA knockdown, cell division phenotype analysis, epistasis analysis\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP/MS plus functional localization and epistasis; single lab\",\n      \"pmids\": [\"20237422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Loss of tuberin in TSC2-null cells promotes invasion through a β-catenin-dependent mechanism; tuberin-null cells express cleaved forms of β-catenin that are transcriptionally active and drive MMP7 expression, which mediates invasion.\",\n      \"method\": \"β-catenin reporter assay, MMP7 expression analysis, invasion assays, TSC2-null cell analysis, LAM tissue immunostaining\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay, expression analysis, and functional invasion assay; single lab with tissue validation\",\n      \"pmids\": [\"20042714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PKG1 (protein kinase G1, a primary effector of nitric oxide and natriuretic peptide signaling) directly phosphorylates TSC2 at S1365/S1366 (mouse; S1364/S1365 human). Phosphorylation at these sites bidirectionally controls stress-stimulated (but not basal) mTORC1 activity, suppressing hypertrophy and stimulating autophagy in cardiomyocytes. Phospho-null knockin (TSC2-S1365A) mice develop worse heart disease after pressure overload; phosphomimetic (TSC2-S1365E) mice are protected.\",\n      \"method\": \"In vitro kinase assay (PKG1 phosphorylates TSC2), phospho-null and phosphomimetic knockin mouse models, cardiac pressure overload model, cardiomyocyte hypertrophy and autophagy assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro kinase assay, bidirectional knockin mouse genetics, in vivo cardiac phenotype with mechanistic rescue\",\n      \"pmids\": [\"30700906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Crystal structure of the TSC2 GAP domain determined; structure-based modeling of the TSC2-Rheb complex and molecular dynamics simulations identify TSC2 Asn1643 and Rheb Tyr35 as key active site residues; Rheb Arg15 and Asp65 contribute to the interface and indirectly aid catalysis rather than being catalytic residues. The GAP domain is stabilized by interactions with other TSC2 domains.\",\n      \"method\": \"X-ray crystallography, molecular dynamics simulations, TSC2-Rheb complex modeling, characterization of pathogenic TSC2 variants\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with MD simulations and mechanistic interpretation; structural validation of catalytic mechanism proposed by Li et al. 2004\",\n      \"pmids\": [\"32502382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Lysosomal biogenesis is increased in TSC1/2-deficient cells via a TFEB-dependent mechanism that is non-canonical: in the absence of TSC1/2, TFEB is hypo-phosphorylated at mTORC1 sites because mTORC1 cannot phosphorylate TFEB without the TSC1/2 complex. Overexpression of FLCN (a RAGC GAP) or constitutively active RAGC increases TFEB phosphorylation and cytoplasmic relocalization in TSC2-deficient cells.\",\n      \"method\": \"TFEB phosphorylation assays in TSC1/2-deficient cells, FLCN overexpression, constitutively active RAGC expression, TFEB localization microscopy, TSC renal tumor/LAM tissue analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays in multiple TSC2-deficient models, FLCN/RAGC rescue; single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"34253722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TSC2 S1365 phosphorylation status controls myocardial substrate utilization during ischemia-reperfusion; TSC2-S1365A (phospho-null) hearts have amplified mTORC1 activation, increased glycolytic capacity, and protection against IR injury; TSC2-S1365E (phosphomimetic) hearts fail to activate mTORC1 with ischemic preconditioning and show worse IR outcomes when glucose is limiting.\",\n      \"method\": \"TSC2-S1365A and S1365E knockin mouse IR model (ex vivo and in vivo), metabolic flux measurements (OCR, EACR), lactate and acylcarnitine metabolomics, mTORC1 substrate phosphorylation\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — bidirectional knockin mouse genetics, metabolomic profiling, and defined metabolic mechanism; extends PKG1/TSC2 mechanistic work\",\n      \"pmids\": [\"33401933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In S. pombe (fission yeast), the defect in arginine uptake in tsc2+ mutant cells (decreased expression of amino acid permeases) is rescued by dominant-negative rhb1+ (Rheb homolog) but not wild-type rhb1+, and is not rescued by a GAP-domain mutant TSC2, placing TSC2 GAP activity toward Rheb upstream of amino acid permease regulation.\",\n      \"method\": \"S. pombe tsc2+ mutant analysis, dominant-negative and wild-type rhb1+ rescue, patient-derived GAP-domain TSC2 mutant complementation, amino acid uptake assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in yeast ortholog with biochemical readout (amino acid uptake), GAP-domain mutation confirms mechanism; fission yeast ortholog\",\n      \"pmids\": [\"14718525\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TSC2 (tuberin) encodes a GTPase-activating protein (GAP) that, together with TSC1 (hamartin), forms a heterodimeric complex that stimulates GTP hydrolysis by Rheb using a catalytic asparagine-thumb mechanism, thereby suppressing mTORC1-dependent translation, cell growth, and anabolic metabolism; the complex is regulated by direct phosphorylation of TSC2 by multiple kinases (Akt, AMPK, ERK, PKG1, cyclin D-CDK) that either activate or inhibit TSC2 GAP activity, and TSC2 protein stability is controlled by the HERC1 and FBW5-DDB1-CUL4-ROC1 ubiquitin ligases, the latter antagonized by TSC1 binding; beyond mTOR regulation, TSC2 controls Rho/Rac-mediated actin cytoskeletal dynamics, cell migration, E-cadherin localization, axon guidance via EphA-ERK-Tsc2 signaling, lysosome biogenesis through RAGC-TFEB, and DNA repair enzyme OGG1 expression via NF-YA, making it a multifunctional integrator of growth factor, energy, and mechanical stress signals.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TSC2 (tuberin) is a multifunctional tumor suppressor that integrates growth-factor, energy, and mechanical-stress signals to restrain cell growth, principally by acting as a GTPase-activating protein (GAP) that drives GTP hydrolysis on the small GTPase Rheb and thereby suppresses mTORC1 signaling [#16, #13]. Its GAP activity resides in a C-terminal GAP-related domain and operates through a non-canonical catalytic 'asparagine thumb' mechanism, with TSC2 Asn1643 and Rheb Tyr35 forming the key active-site contacts defined structurally; missense mutations in this domain found in TSC patients disrupt growth control [#16, #37, #2]. TSC2 functions as a stable heterodimer with TSC1 (hamartin) through reciprocal coiled-coil interactions, and TSC1 binding stabilizes TSC2 by excluding ubiquitin ligases—HERC1 and the FBW5-DDB1-CUL4-ROC1 complex—that otherwise target TSC2 for degradation [#3, #23, #27, #4]. The complex is a signaling hub controlled by direct phosphorylation: Akt, ERK, cyclin D-CDK, and PKG1 phosphorylate TSC2 at distinct sites to dissociate or destabilize the complex and tune mTORC1 output, while AMPK phosphorylation under energy stress enhances TSC2 activity [#8, #9, #20, #22, #36, #15]; phospho-dependent 14-3-3 binding further inhibits TSC2 function [#11, #12]. Reconstitution in TSC2-null cells establishes tuberin as a negative regulator of p70S6K, S6 phosphorylation, and DNA synthesis, downstream of which it controls cell size, proliferation, apoptosis, and metabolism [#13, #15, #26]. Beyond Rheb-mTORC1, TSC2 governs Rho/Rac-dependent actin dynamics, cell adhesion and migration, E-cadherin localization, EphA-ERK-mediated axon guidance, lysosomal biogenesis via RAGC-TFEB, and DNA-repair enzyme OGG1 expression through NF-YA, marking it as a broad integrator of cell physiology [#17, #29, #33, #32, #38, #30]. Pathogenic TSC2 mutations that abolish the TSC1 interface or the GAP domain underlie tuberous sclerosis [#7, #2].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established that the TSC2 product tuberin is an enzyme—a GAP—rather than merely a structural tumor suppressor, defining its biochemical class and localizing the activity to its C-terminus.\",\n      \"evidence\": \"In vitro GTPase assays with native immunoprecipitate and recombinant C-terminal fragment, substrate specificity panel, subcellular fractionation\",\n      \"pmids\": [\"7608212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identified Rap1a, not Rheb, as substrate—the physiological substrate was unresolved\", \"Did not connect GAP activity to a growth-control pathway\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Placed tuberin at the Golgi with its then-presumed substrate Rap1, giving the first spatial context for its GAP function.\",\n      \"evidence\": \"Indirect immunofluorescence with Golgi markers and brefeldin A treatment, confocal microscopy\",\n      \"pmids\": [\"8806680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Golgi residence not reconciled with later mTORC1/lysosomal roles\", \"Did not address whether localization is regulated\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed that the TSC1 and TSC2 products physically associate via coiled-coils, defining the heterodimeric complex that is the functional unit.\",\n      \"evidence\": \"Co-immunoprecipitation from cell lysates and coiled-coil domain mapping\",\n      \"pmids\": [\"9580671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the interaction not yet defined\", \"Stoichiometry and complex architecture unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapped the disease-relevant TSC1-binding interface on TSC2 and demonstrated that pathogenic but not benign mutations abolish complex formation, linking complex integrity to disease.\",\n      \"evidence\": \"Yeast two-hybrid and co-IP with deletion/point mutants discriminating pathogenic from polymorphic variants\",\n      \"pmids\": [\"11741833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish downstream effector pathway\", \"Interface defined by mutagenesis, not structure\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Positioned TSC1-TSC2 in the insulin/PI3K/Akt growth-control pathway through Drosophila genetics, establishing the physiological signaling context.\",\n      \"evidence\": \"Drosophila epistasis and double-mutant rescue of insulin receptor lethality\",\n      \"pmids\": [\"11390358\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target downstream of TSC2 not yet identified\", \"Direct biochemical link to Akt not shown in this work\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated that Akt directly phosphorylates TSC2 to destabilize the complex and relieve mTOR inhibition, defining the core growth-factor-responsive regulatory mechanism and connecting TSC2 to S6K/4E-BP1.\",\n      \"evidence\": \"In vitro kinase assays with site-directed mutagenesis (Ser924/Thr1518 in fly), co-IP, mTOR substrate and stability assays in cells and Drosophila\",\n      \"pmids\": [\"12172553\", \"12172554\", \"12167664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GAP substrate downstream of mTOR inhibition not yet identified as Rheb\", \"Relative contribution of destabilization vs. complex dissociation unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified phospho-dependent 14-3-3 binding as an additional inhibitory input on TSC2, showing TSC2 activity is gated by multiple Akt-regulated mechanisms.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, co-IP with site-specific phospho-mutants, S6K functional assays\",\n      \"pmids\": [\"12364343\", \"12468542\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies with corroboration but no reconstitution\", \"Quantitative contribution of 14-3-3 to physiological mTOR control unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Provided gain-of-function proof that tuberin re-expression suppresses S6/p70S6K signaling and DNA synthesis in TSC2-null cells, with rapamycin epistasis placing mTOR downstream of TSC2.\",\n      \"evidence\": \"Wild-type tuberin reconstitution in multiple TSC2-null cell lines, kinase and DNA synthesis assays, rapamycin treatment\",\n      \"pmids\": [\"12045200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the immediate GTPase substrate linking TSC2 to mTOR\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed energy stress activates TSC2 through direct AMPK phosphorylation, establishing TSC2 as the node integrating energy status with translational control and cell size.\",\n      \"evidence\": \"In vitro AMPK kinase assay, phospho-mutant rescue, cell size and apoptosis assays under energy deprivation\",\n      \"pmids\": [\"14651849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which phosphorylation enhances GAP activity not resolved\", \"Cross-talk with Akt sites not addressed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified Rheb as the physiological GAP substrate and defined the non-canonical asparagine-thumb catalytic mechanism, resolving how TSC2 controls mTORC1.\",\n      \"evidence\": \"Reconstituted in vitro GAP assays with TSC2 and Rheb mutants, cellular S6K functional validation; yeast ortholog epistasis on amino acid permeases\",\n      \"pmids\": [\"15340059\", \"14718525\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of catalytic site not yet available\", \"Role of TSC1 in catalysis vs. regulation incompletely defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established ERK as a second growth-promoting kinase that phosphorylates TSC2 to dissociate the complex, with phospho-null TSC2 suppressing tumorigenicity, linking TSC2 regulation directly to oncogenic transformation.\",\n      \"evidence\": \"In vitro ERK kinase assay, phospho-mutant expression, co-IP for complex integrity, in vivo tumor growth assay\",\n      \"pmids\": [\"15851026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between ERK and Akt phosphorylation sites not dissected\", \"Did not address tissue specificity of ERK input\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed an mTOR-independent role for TSC2 in actin cytoskeletal dynamics, cell adhesion, and migration through Rho/Rac regulation, broadening TSC2 function beyond growth control.\",\n      \"evidence\": \"Domain-specific (HBD/N-terminal) rescue in TSC2-null cells, Rho/Rac pull-down assays, TSC1 siRNA, migration/invasion assays; neuronal conditional knockout with LIM-kinase/cofilin readout\",\n      \"pmids\": [\"15611338\", \"16388022\", \"16286931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which TSC2 modulates Rho/Rac GTPases not biochemically defined\", \"Relationship between GAP-independent and GAP-dependent functions unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the ubiquitin-ligase machinery controlling TSC2 stability and showed TSC1 protects TSC2 by excluding these ligases, establishing degradation as a key regulatory layer.\",\n      \"evidence\": \"Co-IP of FBW5-DDB1-CUL4-ROC1 with TSC2, siRNA depletion, stability assays, Drosophila genetics; earlier HERC1 competitive-binding work\",\n      \"pmids\": [\"18381890\", \"16464865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals that trigger ligase-mediated TSC2 turnover not defined\", \"Relative contribution of HERC1 vs. CUL4 ligase in vivo unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected TSC2 to neuronal development via EphA-ERK signaling and to epithelial integrity via E-cadherin localization, extending its role into axon guidance and EMT control.\",\n      \"evidence\": \"Tsc2+/- mouse retinogeniculate analysis with growth cone collapse assays; Tsc2-null cell E-cadherin/EMT analysis with rapamycin and CLIP170 knockdown\",\n      \"pmids\": [\"20062052\", \"20813961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation hierarchy in vivo only partially mapped\", \"E-cadherin pathway dissected in single-lab cell models\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified PKG1 as a stress-specific kinase phosphorylating TSC2 at S1365/S1366 to bidirectionally tune mTORC1, providing in vivo genetic proof in the heart and a therapeutically tractable regulatory node.\",\n      \"evidence\": \"In vitro PKG1 kinase assay plus phospho-null and phosphomimetic knockin mouse cardiac pressure-overload and ischemia-reperfusion models with metabolic profiling\",\n      \"pmids\": [\"30700906\", \"33401933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability of S1365 regulation beyond cardiac tissue not established\", \"Mechanism by which these sites selectively affect stress-stimulated mTORC1 unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided the crystal structure of the TSC2 GAP domain and a TSC2-Rheb model, validating the asparagine-thumb mechanism at atomic resolution and reinterpreting the roles of interface residues.\",\n      \"evidence\": \"X-ray crystallography, molecular dynamics simulations, pathogenic variant characterization\",\n      \"pmids\": [\"32502382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental TSC1-TSC2-Rheb holocomplex structure\", \"Conformational regulation by phosphorylation not captured\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Uncovered a non-canonical TSC1/2 requirement for mTORC1-mediated TFEB phosphorylation, explaining elevated lysosomal biogenesis in TSC-deficient cells through the RAGC-TFEB axis.\",\n      \"evidence\": \"TFEB phosphorylation/localization assays in TSC1/2-deficient cells, FLCN and constitutively active RAGC rescue, TSC tumor tissue analysis\",\n      \"pmids\": [\"34253722\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study; mechanism by which TSC1/2 enables TFEB phosphorylation not fully defined\", \"In vivo relevance of TFEB axis to TSC pathology incompletely established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many phosphorylation inputs (Akt, ERK, AMPK, PKG1, cyclin D-CDK) are integrated combinatorially to set TSC2 GAP output in a given cell state, and how GAP-independent functions (Rho/Rac, adhesion, mitosis) are biochemically executed, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of multi-site phosphorylation integration\", \"Biochemical basis of GAP-independent cytoskeletal and mitotic roles undefined\", \"No structure of the regulated holocomplex with bound effectors\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005096\", \"supporting_discovery_ids\": [0, 16, 37]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 23, 27]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [13, 16, 32]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1, 19]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [28, 26]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [25, 26]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [19, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 16, 20, 36]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [15, 39]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [36, 38]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [21, 32]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"complexes\": [\"TSC1-TSC2 complex\", \"DDB1-CUL4-ROC1-FBW5 ubiquitin ligase complex\"],\n    \"partners\": [\"TSC1\", \"RHEB\", \"AKT1\", \"AMPK\", \"MAPK1/ERK\", \"PRKG1\", \"FBW5\", \"TACC3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}